← Leaderboards
Adam Burgener
University Of Washington
$2,232,629
Attributed
$4,970,833
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2017–25$2M$1.5M$1M$500K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,970,833 · 3
By mechanism
R01$4,970,833 · 3
Top collaborators
- Nichole Rose Klatt7 shared
- Stefanie Avril4 shared
- Thomas Hope3 shared
Most similar at University Of Washington
Same institution · by research overlap
- Connie L Celum$55,222,861
- Raymond Scott McClelland$25,618,064
- Nichole Rose Klatt$11,307,630
- Anna Wald$34,443,936
- Pamela J Fink$12,911,564
Others in their field
Other Emerging Leaders on “Microbiome”
- Kathleen Maletic Neuzil · Emory University$27,446,978
- Gary Fanger · Rise Therapeutics, Llc$20,685,951
- Sacha Gnjatic · Icahn School Of Medicine At Mount Sinai$18,174,878
- Jeremy James Martinson · University Of Pittsburgh At Pittsburgh$17,624,257
- Angela Ramona Branche · University Of Rochester$10,119,005
- Dong Wang · Harvard School Of Public Health$10,115,742
Research focus
MicrobiomeLinkPathway InteractionsPhenotypeInflammatoryMicrobialCellsSamplingTissuesInflammationProteinsMucous MembranePathogenesisPathologyImmune ResponseBacteriaMucosal ImmunityImmuneFunctional DisorderEpitheliumIn VivoLactobacillusBaseFemale
Grant awards (11)
The Microbiome and Mucosal Immunity in Cervical Cancer Disparities$608,613
R01 · FY2025 · CA · contact PI
The Microbiome and Mucosal Immunity in Cervical Cancer Disparities$531,423
R01 · FY2024 · CA · contact PI
The Microbiome and Mucosal Immunity in Cervical Cancer Disparities$548,284
R01 · FY2023 · CA · contact PI
The Microbiome and Mucosal Immunity in Cervical Cancer Disparities$559,473
R01 · FY2022 · CA · contact PI
Targeting novel pathways to enhance gastrointestinal integrity during HIV infection$315,803
R01 · FY2021 · DK
Mucosal mechanisms of altered HIV susceptability in adolescents$513,062
R01 · FY2020 · AI
Targeting novel pathways to enhance gastrointestinal integrity during HIV infection$350,991
R01 · FY2020 · DK
Mucosal mechanisms of altered HIV susceptibility in adolescents$281,171
R01 · FY2018 · AI
Targeting novel pathways to enhance gastrointestinal integrity during HIV infection$160,120
R01 · FY2018 · DK
Mucosal mechanisms of altered HIV susceptibility in adolescents$722,492
R01 · FY2017 · AI
Targeting novel pathways to enhance gastrointestinal integrity during HIV infection$379,401
R01 · FY2017 · DK